由于脱硫剂中毒引起的急性呼吸窘迫综合征:一个病例报告
1Department of Critical Care Medicine, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou 511400, Guangdong Province, China. yukoky_yang@163.com.
World journal of radiology
|December 5, 2024
概括
本案例报告详细介绍了第一个急性呼吸系统应急综合征 (ARDS) 病例,该病例是由除硫剂气体吸入引起的. 它强调了这种化学品对肺部的严重风险,以及需要加强工作场所安全措施.
科学领域:
- 职业健康 职业健康 职业健康
- 毒理学 毒理学 毒理学
- 肺部医学 肺部医学
背景情况:
- 脱硫剂气是一种常见的工业化学品,具有潜在的肺毒性.
- 急性呼吸应急综合征 (ARDS) 是一种严重的肺部疾病.
- 本报告记录了第一个已知的ARDS病例,该病例是由除剂气体吸入引起的.
相关概念视频
Acute Respiratory Failure-I
167
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
167
Acute Respiratory Failure-II
174
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
174
Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123


